ZDRAVESKI ZORAN 4
4 · Magenta Therapeutics, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
ZDRAVESKI ZORAN
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2021-02-11+67,700→ 67,700 totalExercise: $10.80Exp: 2031-02-10→ Common Stock (67,700 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable in 16 equal quarterly installments beginning on January 1, 2021.